AETN AETERNUM HEALTH, INC.

Overview and Growth

In fiscal 2025, AETERNUM HEALTH, INC. recorded $203.66K of revenue, net loss of $337.09K, and an operating cash outflow of $2.96K. At $203.66K, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. The top line expanded 212.7% from $65.12K in fiscal 2024, increasing the company’s operating scale. The company reported diluted EPS of -$0.01, adding a shareholder-level measure to the absolute income figures considered below. Diluted shares averaged 49.05M; this is the reported share base over which the company’s diluted per-share earnings were spread. The diluted share count was 1.2% higher than fiscal 2024, when diluted shares averaged 48.48M, adding context to the EPS comparison. The company employed $54.56K of total assets, the balance-sheet base supporting its current operating and cash-flow results. The revenue-to-assets relationship was 3.73x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

After reported cost of revenue, the company retained $120.05K as gross profit before recognizing operating expenses and other items. Gross margin was 58.9%, so that share of each revenue unit remained after the cost of revenue reported for the period. Operations produced a $269.27K operating loss before non-operating and tax effects. The operating loss equaled 132.2% of revenue, showing the scale of the operating deficit relative to sales. After all below-operating-line items, the company recorded a net loss of $337.09K for the fiscal year. Measured against revenue, the bottom-line deficit represented 165.5% after all recognized items. The loss-to-assets relationship was 617.9%, placing the bottom-line deficit against the company’s resource base. The net loss narrowed to $337.09K from $450.32K in fiscal 2024.

Liquidity and Capital Structure

The company held $54.56K of assets against $2.05M of liabilities and -$2.00M of equity, revealing how the asset base was financed. With total equity at -$2.00M, the company carried a negative book-capital position, increasing its reliance on liabilities and future earnings. Current assets were $53.56K against $1.13M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. Current assets covered only 0.05x of current liabilities, so current liabilities exceeded current assets at period end. Cash and equivalents totaled $0.00, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 0.0% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. The cash-to-assets relationship was 0.0%, comparing reported cash and equivalents with the full positive asset balance. Compared with $65.42K in fiscal 2024, the current asset base moved 16.6% and finished lower.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $2.96K, rather than cash generation from operations. Compared with a $154.05K operating cash outflow in fiscal 2024, the current outflow improved to $2.96K.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.